MicroPort Scientific Corporation (MCRPF) Research

MicroPort Scientific Corporation functions as an investment holding company, primarily engaged in the development, manufacturing, marketing, and global distribution of diverse medical devices. Its expansive market reach encompasses the People's Republic of China, North America, Europe, various other Asian nations, South America, and additional international territories. The enterprise is structured into several specialized divisions: Cardiovascular Devices: This segment provides an array of products and services tailored for addressing coronary artery-related conditions, including coronary stents, their accompanying delivery systems, and balloon catheters with related accessories. Orthopedics Devices: Focuses on offerings such as reconstructive joint components, spinal and trauma implants, alongside other professional-grade instruments and implants. Cardiac Rhythm Management Business: Delivers critical medical technology, including defibrillators, cardiac resynchronization therapy (CRT) devices, and pacemakers, which are instrumental in the diagnosis, treatment, and ongoing management of heart rhythm disorders and heart failure. Endovascular and Peripheral Vascular Devices: Offers comprehensive product solutions and services for the interventional treatment of a range of conditions, such as thoracic and abdominal aortic aneurysms, peripheral vascular diseases, aortic dissection, and other endovascular-related ailments. Neurovascular Devices: Dedicated to providing therapeutic and access devices specifically designed for neurovascular diseases. Heart Valve Business: Encompasses an extensive portfolio of heart valve solutions, featuring products like the VitaFlow Transcatheter aortic valve and its delivery system, the VitaFlow Liberty Transcatheter aortic valve implantation (TAVI) and retrievable delivery systems, the Alwide Plus Balloon Catheter, various other TAVI, transcatheter mitral valve (TMV), transcatheter tricuspid valve (TTV), and surgical valve products. Surgical Robot Business: Actively involved in the conception, advancement, and commercialization of surgical robots, integrating elements such as robot ontology, sophisticated control algorithms, electrical engineering, image-based navigation capabilities, and precision imaging. Surgical Devices: Engages in the research, development, production, and sale of general surgical devices. MicroPort Scientific Corporation was established in 1998 and maintains its corporate headquarters in Shanghai, People's Republic of China.

Open MicroPort Scientific Corporation (MCRPF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.